Amelioration of Immune Complex-Mediated Glomerulonephritis via CD6 Modulation

被引：0
|
作者：
Chalmers, Samantha [1 ]
Garcia, Sayra [1 ]
Herlitz, Leal [2 ]
Ampudia, Jeanette [3 ]
Ng, Cherie [4 ]
Connelly, Stephen [3 ]
Putterman, Chaim [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Equillium Inc, San Diego, CA USA
[4] Equillium Inc, La Jolla, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0840
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immune complex-mediated glomerulonephritis with ANCA positivity: what should nephrologists consider?
    Tomoki Taniguchi
    CEN Case Reports, 2024, 13 : 141 - 142
  • [32] Suppression of immune complex-mediated glomerulonephritis by mouse apolipoprotein J/clusterin.
    Barrie, AMM
    Zhu, G
    Bissler, JJ
    Chmielewski, D
    Santilez, J
    Wills-Karp, M
    Harmony, JAK
    Witte, DP
    Rosenberg, ME
    Aronow, BJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 134A - 134A
  • [33] Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis
    Guo, Shunhua
    Kowalewska, Jolanta
    Wietecha, Tomasz A.
    Iyoda, Masayuki
    Wang, Li
    Yi, Kenneth
    Spencer, Min
    Banas, Miriam
    Alexandrescu, Sanda
    Hudkins, Kelly L.
    Alpers, Charles E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (06): : 1168 - 1176
  • [34] Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis A Comparative Consecutive Series
    Dalvin, Lauren A.
    Fervenza, Fernando C.
    Sethi, Sanjeev
    Pulido, Jose S.
    OPHTHALMOLOGY, 2016, 123 (07) : 1588 - 1594
  • [35] PROTEASE INHIBITOR AMELIORATION OF IMMUNE-COMPLEX MEDIATED NECROTIZING GLOMERULONEPHRITIS (NGN)
    GILLESPIE, GY
    JENNETTE, JC
    TIDWELL, RR
    GERATZ, JD
    FALK, RJ
    KIDNEY INTERNATIONAL, 1986, 29 (01) : 275 - 275
  • [36] Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy
    Bomback, Andrew S.
    Charu, Vivek
    Fakhouri, Fadi
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (01): : 17 - 28
  • [37] Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis
    Zhang, Ping L.
    Metcalf, Brandon D.
    Khan, Sarang
    Abukhaled, Jamal
    Zafar, Khalid
    Li, Wei
    Kanaan, Hassan D.
    ULTRASTRUCTURAL PATHOLOGY, 2024, 48 (04) : 317 - 322
  • [38] Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency
    Bruno, Nelson E.
    Yano, Yutaka
    Takei, Yoshiyuki
    Qin, Liqiang
    Suzuki, Toshinari
    Morser, John
    D'Alessandro-Gabazza, Corina N.
    Mizoguchi, Akira
    Suzuki, Koji
    Taguchi, Osamu
    Gabazza, Esteban C.
    Sumida, Yasuhiro
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (01) : 90 - 100
  • [39] Mantle cell lymphoma first presenting as immune complex-mediated glomerulonephritis: A case report
    Abeysekera R.A.
    Wazil A.W.M.
    Nanayakkara N.
    Ratnatunga N.
    Fernando K.M.
    Thinnarachchi J.
    Journal of Medical Case Reports, 9 (1)
  • [40] LYMPHOCYTOTOXIC ACTIVITY IN PRIMARY GLOMERULONEPHRITIS - EVIDENCE FOR IMMUNE COMPLEX-MEDIATED CYTO-TOXICITY
    CHARLESWORTH, JA
    BOWMAN, C
    PERL, SI
    YASMEEN, D
    PUSSELL, BA
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1981, 6 (03) : 233 - 236
12345